dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | Genescà, Eulàlia |
dc.contributor.author | González Gil, Celia |
dc.contributor.author | Fuster-Tormo, Francisco |
dc.contributor.author | Haferlach, Claudia |
dc.contributor.author | Meggendorfer, Manja |
dc.contributor.author | Barba Suñol, Pere |
dc.contributor.author | Morgades, Mireia |
dc.date.accessioned | 2022-06-14T07:29:05Z |
dc.date.available | 2022-06-14T07:29:05Z |
dc.date.issued | 2021-10 |
dc.identifier.citation | Genescà E, Morgades M, González-Gil C, Fuster-Tormo F, Haferlach C, Meggendorfer M, et al. Adverse prognostic impact of complex karyotype (≥3 cytogenetic alterations) in adult T-cell acute lymphoblastic leukemia (T-ALL). Leuk Res. 2021 Oct;109:106612. |
dc.identifier.issn | 0145-2126 |
dc.identifier.uri | https://hdl.handle.net/11351/7676 |
dc.description | Citogenètica; Pronòstic; Teràpia |
dc.description.sponsorship | This project was supported by the AECC (GC16173697BIGA); ISCIII (PI19/01828) co-funded by ERDF/ESF "A way to make Europe"/"Investing in your future", CERCA/Generalitat de Catalunya SGR 2017 288 (GRC)/ “La Caixa” P. Barba was supported by the Instituto de Salud Carlos III FIS16/01433 and PERIS 2018-2020 from Generalitat de Catalunya (BDNS357800). |
dc.language.iso | eng |
dc.publisher | Elsevier |
dc.relation.ispartofseries | Leukemia Research;109 |
dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ |
dc.source | Scientia |
dc.subject | Leucèmia limfoblàstica - Prognosi |
dc.subject | Anomalies cromosòmiques |
dc.subject.mesh | Precursor Cell Lymphoblastic Leukemia-Lymphoma |
dc.subject.mesh | Prognosis |
dc.subject.mesh | Chromosome Aberrations |
dc.title | Adverse prognostic impact of complex karyotype (≥3 cytogenetic alterations) in adult T-cell acute lymphoblastic leukemia (T-ALL) |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.1016/j.leukres.2021.106612 |
dc.subject.decs | leucemia-linfoma linfoblástico de células precursoras |
dc.subject.decs | pronóstico |
dc.subject.decs | aberraciones cromosómicas |
dc.relation.publishversion | https://doi.org/10.1016/j.leukres.2021.106612 |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.organismes | Institut Català de la Salut |
dc.contributor.authoraffiliation | [Genescà E, González-Gil C, Fuster-Tormo F] Josep Carreras Leukaemia Research Institute (IJC), Campus ICO-Hospital Germans Trias i Pujol, Universitat Autònoma de Barcelona (UAB), Badalona, Spain. [Morgades M] Josep Carreras Leukaemia Research Institute (IJC), Campus ICO-Hospital Germans Trias i Pujol, Universitat Autònoma de Barcelona (UAB), Badalona, Spain. Clinical Hematology Department, ICO-Hospital Germans Trias i Pujol, Badalona, Spain. [Haferlach C, Meggendorfer M] MLL Munich Leukemia Laboratory, Munich, Germany. [Barba P] Servei d’Hematologia Clínica, Vall d'Hebron Hospital Universitari, Barcelona, Spain |
dc.identifier.pmid | 34139642 |
dc.identifier.wos | 000696732800016 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |